Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report

por Sadaat, Masood, Jang, Sekwon
Publicado 2018

Brentuximab-induced hand-foot syndrome in a patient with cutaneous T-cell lymphoma

por Shaposhnik, Guy, Jang, Sekwon, DeSimone, Jennifer A.
Publicado 2022

Oral mycosis fungoides with CD30(+) large cell transformation successfully treated with brentuximab vedotin

por Goggins, Clare A., Gocke, M. Timothy, Jang, Sekwon, DeSimone, Jennifer A.
Publicado 2019

Correction to: Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma

por Jang, Sekwon, Poretta, Tayla, Bhagnani, Tarun, Harshaw, Qing, Burke, Matthew, Rao, Sumati
Publicado 2020

Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma

por Jang, Sekwon, Poretta, Tayla, Bhagnani, Tarun, Harshaw, Qing, Burke, Matthew, Rao, Sumati
Publicado 2020

Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot Study

por Steimer, Mary, Leabo, Jessica, Wang, Hongkun, Heyer, David, Addison, Nancy, Bowles, Nancy, Cannon, Timothy L., Cuevo, Raymund, Ershler, William B., Shafer, Danielle, Jang, Sekwon, Pennisi, Angela, Al-Hussain, Amjaad, Farrell, Kirby, Deeken, John F.
Publicado 2021

Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms

por Abbott, Charles W., Boyle, Sean M., Pyke, Rachel Marty, McDaniel, Lee D., Levy, Eric, Navarro, Fábio C.P., Mellacheruvu, Dattatreya, Zhang, Simo V., Tan, Mengyao, Santiago, Rose, Rusan, Zeid M., Milani, Pamela, Bartha, Gabor, Harris, Jason, McClory, Rena, Snyder, Michael P., Jang, Sekwon, Chen, Richard
Publicado 2021

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma

por Diab, Adi, Tykodi, Scott S., Daniels, Gregory A., Maio, Michele, Curti, Brendan D., Lewis, Karl D., Jang, Sekwon, Kalinka, Ewa, Puzanov, Igor, Spira, Alexander I., Cho, Daniel C., Guan, Shanhong, Puente, Erika, Nguyen, Tuan, Hoch, Ute, Currie, Sue L., Lin, Wei, Tagliaferri, Mary A., Zalevsky, Jonathan, Sznol, Mario, Hurwitz, Michael E.
Publicado 2021

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

por Tawbi, Hussein A, Forsyth, Peter A, Hodi, F Stephen, Lao, Christopher D, Moschos, Stergios J, Hamid, Omid, Atkins, Michael B, Lewis, Karl, Thomas, Reena P, Glaspy, John A, Jang, Sekwon, Algazi, Alain P, Khushalani, Nikhil I, Postow, Michael A, Pavlick, Anna C, Ernstoff, Marc S, Reardon, David A, Puzanov, Igor, Kudchadkar, Ragini R, Tarhini, Ahmad A, Sumbul, Anne, Rizzo, Jasmine I, Margolin, Kim A
Publicado 2021

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

por Slingluff, Craig L, Lewis, Karl D, Andtbacka, Robert, Hyngstrom, John, Milhem, Mohammed, Markovic, Svetomir N, Bowles, Tawnya, Hamid, Omid, Hernandez-Aya, Leonel, Claveau, Joel, Jang, Sekwon, Philips, Prejesh, Holtan, Shernan G, Shaheen, Montaser F, Curti, Brendan, Schmidt, William, Butler, Marcus O, Paramo, Juan, Lutzky, Jose, Padmanabhan, Arvinda, Thomas, Sajeve, Milton, Daniel, Pecora, Andrew, Sato, Takami, Hsueh, Eddy, Badarinath, Suprith, Keech, John, Kalmadi, Sujith, Kumar, Pallavi, Weber, Robert, Levine, Edward, Berger, Adam, Bar, Anna, Beck, J Thaddeus, Travers, Jeffrey B, Mihalcioiu, Catalin, Gastman, Brian, Beitsch, Peter, Rapisuwon, Suthee, Glaspy, John, McCarron, Edward C, Gupta, Vinay, Behl, Deepti, Blumenstein, Brent, Peterkin, Joanna J
Publicado 2021